Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
23 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss
Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
22 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss
Corporate/M&A & capital markets
Click here to find out more
The Beginning of a new Blockchain Era in Germany
31 October 2019
by Alexander R. Roth, M.Jur. (Oxford) and Dr. Daniel Schrembs, LL.M. (Duke University)